These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31511712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
    Wu Y, Ma J, Wang Y, Zhang Y, Hou Y, Zhang C, Sun H, Sun J, Wang Z, Li N.
    Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C.
    PLoS One; 2016 Jul; 11(4):e0153227. PubMed ID: 27070780
    [Abstract] [Full Text] [Related]

  • 10. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY, Li N, Ding HG, Jiang FF.
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [Abstract] [Full Text] [Related]

  • 11. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
    Yang Y, Xiao L, Mao R, Zhang H, Wen H, Zhao HR, He FP, Zhang YF, Bao YX.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
    [Abstract] [Full Text] [Related]

  • 12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 13. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH.
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [Abstract] [Full Text] [Related]

  • 14. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
    Wu QP, Xie FY, Meng QL, Mu YY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
    [Abstract] [Full Text] [Related]

  • 15. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y, Wang M, Cui C, Zhang L, Liao F, Li H, Wu X.
    Cancer Biomark; 2015 Apr; 15(5):677-83. PubMed ID: 26406957
    [Abstract] [Full Text] [Related]

  • 16. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 17. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Aug; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 18. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L.
    Zhonghua Yi Xue Za Zhi; 2014 Feb 11; 94(5):390-2. PubMed ID: 24746091
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y, Liu YH, Mai SJ, He LJ, Liao YJ, Deng HX, Guan XY, Zeng YX, Kung HF, Xie D.
    J Gastroenterol Hepatol; 2010 Jun 11; 25(6):1123-8. PubMed ID: 20594228
    [Abstract] [Full Text] [Related]

  • 20. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, Chan DW, Dowell BL.
    Clin Chem Lab Med; 2011 Apr 11; 49(4):711-8. PubMed ID: 21231906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.